Kinesia ONE

Kinesia ONE objectively measures Parkinson’s disease motor symptoms including tremor, bradykinesia, and dyskinesia.  Indivudials interact with the Kinesia ONE iPad app while wearing a motion sensor to evaluate symptom severity.  The Kinesia ONE system can be used in the clinic, or at the patient’s home.

previous arrow
next arrow

Task-Based Motor Assessments

For Parkinson’s Disease and Essential Tremor

The Kinesia ONE™ motor assessment system provides highly sensitive motor symptom assessment by having the patient perform brief pre-defined tasks based on common rating scales (e.g., UPDRS, TETRAS). A mobile application guides the patient through donning the motion sensor on their finger or heel, and provides intuitive instructions for completing the assessment tasks. Data from the motion sensor is uploaded to the Kinesia Web Portal in real-time and algorithms are used to calculate severity scores on a 0-4 rating scale shown to be highly correlated with clinician ratings.

Kinesia ONE Tasks and Outcome Measures

Task Outcome Measure(s)
Arms resting Resting tremor, dyskinesia
Arm(s) extended Postural tremor, dyskinesia
Wing-beating posture Postural tremor
Finger-to-nose Kinetic tremor
Finger-chin-finger Kinetic tremor
Finger-tapping Bradykinesia (speed, amplitude, and rhythm)
Hand-grasping Bradykinesia (speed, amplitude, and rhythm)
Pronation-supination Bradykinesia (speed, amplitude, and rhythm)
Toe-tapping Bradykinesia
Leg lifts Leg agility
Walking and turning Gait, freezing of gait

Validated        Reliable        Real-time        Secure

The Sensor

The Kinesia ONE sensor is worn on the finger during specific tasks used to assess symptoms. The sensor transmits motion data wirelessly to the tablet using a Bluetooth radio. (The Sensor includes a triaxial accelerometer, triaxial gyroscope, Bluetooth radio and wireless recharging).

Kinesia ONE Tablet Software

The tablet is preloaded with the Kinesia ONE software and instructs patients on how to perform each assessment. Great Lakes NeuroTechnologies also provides mobile device management to ensure software is always current and controlled. Kinesia ONE software has been translated into English, Spanish, French, German, and Swedish and may be translated into additional languages upon request.

Secure Web Portal

Once an assessment has been completed, motion data is transmitted from the tablet to the cloud via mobile broadband or Wi-Fi to a cloud database that complies with 21 CFR Part 11. Clinicians and researchers access their data and reports real-time by logging into the Kinesia web portal.

Kinesia ONE Reports

The Kinesia ONE reports provide objective motor scores each time an assessment is performed. Symptom scores ranging from 0 (no symptoms) to 4 (severe symptoms) are calculated by clinically validated algorithms shown to be highly correlated with expert clinical ratings. (Customized data reporting is available)

Click HERE for a complete list of clinical validation publications.

Kinesia™ products are used as outcome measures in Phase I, II, III and IV clinical trials.

Kinesia technology is integrated in clinical trials around the globe for Parkinson’s disease, essential tremor and other movement disorders. Intelligent remote sensing technology increases the sensitivity and reliability of outcome measures, improves efficiency with web applications and expands accessibility.  To view publications, please click HERE

The Kinesia ONE motor assessment system is cleared for sale as a medical device in the US, Europe, Canada, and Australia and can be used in many countries worldwide in clinical trials when labeled for research-use only and approved by an IRB.
The Kinesia ONE motor assessment system is intended to monitor physical motion and muscle activity to quantify kinematics of movement disorder symptoms such as tremor and assess activity in any instance where quantifiable analysis of motion and muscle activity is desired. In Canada, the Kinesia ONE system may only be used for therapeutic (not diagnostic) purposes of non-serious situations or conditions.